TIRZ (Tirzepatide) is a dual GIP and GLP-1 receptor agonist studied for its effects on appetite regulation, blood glucose control, and body weight. Its dual-action mechanism makes it a compound of interest in metabolic research.
Supplied in a lyophilized (freeze-dried) powder form to maintain stability, purity, and integrity. Designed for reconstitution prior to use in controlled research settings.
All products are sold strictly for laboratory research purposes only. They are not intended for human or animal consumption, and are not to be used for clinical, therapeutic, or veterinary applications. These products are are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer acknowledges that these products are for research use only and assumes all responsibility for their use.
